Impact of a Citywide Benchmarking Intervention on Colonoscopy Quality Performance.


Journal

Digestive diseases and sciences
ISSN: 1573-2568
Titre abrégé: Dig Dis Sci
Pays: United States
ID NLM: 7902782

Informations de publication

Date de publication:
09 2020
Historique:
received: 27 10 2019
accepted: 09 01 2020
pubmed: 10 2 2020
medline: 30 12 2020
entrez: 10 2 2020
Statut: ppublish

Résumé

There is marked variability in colonoscopy quality, limiting its effectiveness in colorectal cancer prevention. Multiple indicators have been established as markers for colonoscopy quality; however, there are conflicting data on the effects of quality reporting programs on endoscopist performance. In this study, we investigate the impact of a multicenter quarterly report card initiative on colonoscopy quality metric performance. Data were collected from 194 endoscopists at 10 participating sites throughout New York City using a Qualified Clinical Data Registry from January 2013 to December 2014. Adenoma detection rate (ADR), cecal intubation rate, withdrawal time, bowel preparation quality and appropriate interval recommendations were tracked. Report cards were distributed to each site on a quarterly basis and technical assistance was provided as needed. Performance trends were analyzed using the Cochran-Armitage trend and analysis of variance tests. 37,258 screening colonoscopies were performed during the study period. There was a positive performance trend for ADR over time from the first quarter of 2013 to the last quarter of 2014 (15.6-25.7%; p < 0.001). There were also increases in cecal intubation rates (78.2-92.6%; p < 0.001), bowel preparation adequacy rates (77.5-92.8%; p < 0.001), and adherence to appropriate screening intervals (28.0-55.0%; p < 0.001). There was no clinically significant change in mean withdrawal time. The implementation of a quarterly report card initiative resulted in statistically significant improvements in adenoma detection, cecal intubation, bowel preparation adequacy rates, and appropriate recommended screening intervals.

Identifiants

pubmed: 32036513
doi: 10.1007/s10620-020-06067-y
pii: 10.1007/s10620-020-06067-y
doi:

Types de publication

Journal Article Multicenter Study Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

2534-2541

Subventions

Organisme : CDC HHS
ID : IU58DP0000783
Pays : United States

Références

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7–34.
Singh H, Turner D, Xue L, Targownik LE, Bernstein CN. Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies. JAMA. 2006;295:2366–2373.
doi: 10.1001/jama.295.20.2366
Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med. 2000;343:162–168.
doi: 10.1056/NEJM200007203430301
Lieberman DA, Weiss DG. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med. 2001;345:555–560.
doi: 10.1056/NEJMoa010328
Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993;329:1977–1981.
doi: 10.1056/NEJM199312303292701
Zauber AG, Winawer SJ, O’brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366:687–696.
doi: 10.1056/NEJMoa1100370
Kahi CJ, Imperiale TF, Juliar BE, Rex DK. Effect of screening colonoscopy on colorectal cancer incidence and mortality. Clin Gastroenterol Hepatol. 2009;7:770–775.
doi: 10.1016/j.cgh.2008.12.030
Singh S, Singh PP, Murad MH, Singh H, Samadder NJ. Prevalence, risk factors, and outcomes of interval colorectal cancers: a systematic review and meta-analysis. Am J Gastroenterol. 2014;109:1375–1389.
doi: 10.1038/ajg.2014.171
Robertson DJ, Lieberman DA, Winawer SJ, et al. Colorectal cancers soon after colonoscopy: a pooled multicohort analysis. Gut. 2014;63:949–956.
doi: 10.1136/gutjnl-2012-303796
Van rijn JC, Reitsma JB, Stoker J, Bossuyt PM, Van deventer SJ, Dekker E. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol. 2006;101:343–350.
doi: 10.1111/j.1572-0241.2006.00390.x
Kaminski MF, Regula J, Kraszewska E, et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med. 2010;362:1795–1803.
doi: 10.1056/NEJMoa0907667
Corley DA, Jensen CD, Marks AR, et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014;370:1298–1306.
doi: 10.1056/NEJMoa1309086
Baxter NN, Sutradhar R, Forbes SS, Paszat LF, Saskin R, Rabeneck L. Analysis of administrative data finds endoscopist quality measures associated with postcolonoscopy colorectal cancer. Gastroenterology. 2011;140:65–72.
doi: 10.1053/j.gastro.2010.09.006
Barclay RL, Vicari JJ, Doughty AS, Johanson JF, Greenlaw RL. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Engl J Med. 2006;355:2533–2541.
doi: 10.1056/NEJMoa055498
Lebwohl B, Kastrinos F, Glick M, Rosenbaum AJ, Wang T, Neugut AI. The impact of suboptimal bowel preparation on adenoma miss rates and the factors associated with early repeat colonoscopy. Gastrointest Endosc. 2011;73:1207–1214.
doi: 10.1016/j.gie.2011.01.051
Harewood GC, Sharma VK, De garmo P. Impact of colonoscopy preparation quality on detection of suspected colonic neoplasia. Gastrointest Endosc. 2003;58:76–79.
doi: 10.1067/mge.2003.294
Rex DK, Schoenfeld PS, Cohen J, et al. Quality indicators for colonoscopy. Gastrointest Endosc. 2015;81:31–53.
doi: 10.1016/j.gie.2014.07.058
Rex DK, Bond JH, Winawer S, et al. Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2002;97:1296–1308.
doi: 10.1111/j.1572-0241.2002.05812.x
Corley DA, Jensen CD, Marks AR. Can we improve adenoma detection rates? A systematic review of intervention studies. Gastrointest Endosc. 2011;74:656–665.
doi: 10.1016/j.gie.2011.04.017
Kahi CJ, Ballard D, Shah AS, Mears R, Johnson CS. Impact of a quarterly report card on colonoscopy quality measures. Gastrointest Endosc. 2013;77:925–931.
doi: 10.1016/j.gie.2013.01.012
Inra JA, Nayor J, Rosenblatt M, et al. Comparison of colonoscopy quality measures across various practice settings and the impact of performance scorecards. Dig Dis Sci. 2017;62:894–902. https://doi.org/10.1007/s10620-016-4410-0 .
doi: 10.1007/s10620-016-4410-0 pubmed: 27995405
Keswani RN, Yadlapati R, Gleason KM, et al. Physician report cards and implementing standards of practice are both significantly associated with improved screening colonoscopy quality. Am J Gastroenterol. 2015;110:1134–1139.
doi: 10.1038/ajg.2015.103
Abdul-baki H, Schoen RE, Dean K, et al. Public reporting of colonoscopy quality is associated with an increase in endoscopist adenoma detection rate. Gastrointest Endosc. 2015;82:676–682.
doi: 10.1016/j.gie.2014.12.058
Chen SC, Rex DK. Endoscopist can be more powerful than age and male gender in predicting adenoma detection at colonoscopy. Am J Gastroenterol. 2007;102:856–861.
doi: 10.1111/j.1572-0241.2006.01054.x
Sanchez W, Harewood GC, Petersen BT. Evaluation of polyp detection in relation to procedure time of screening or surveillance colonoscopy. Am J Gastroenterol. 2004;99:1941–1945.
doi: 10.1111/j.1572-0241.2004.40569.x
Uche-anya EN, Decuir N, Lebwohl B. Temporal trends and risk factors for postcolonoscopy colorectal cancer. J Clin Gastroenterol. 2018;53:e334–e340.
doi: 10.1097/MCG.0000000000001099
Murthy SK, Benchimol EI, Tinmouth J, et al. Temporal trends in postcolonoscopy colorectal cancer rates in 50- to 74-year-old persons: a population-based study. Gastrointest Endosc. 2018;87:1324–1334.e4.
doi: 10.1016/j.gie.2017.12.027
Itzkowitz SH, Winawer SJ, Krauskopf M, et al. New York citywide colon cancer control coalition: a public health effort to increase colon cancer screening and address health disparities. Cancer. 2016;122:269–277.
doi: 10.1002/cncr.29595
New York City Department of Health and Mental Hygiene. Epiquery: NYC Interactive Health Data System—Community Health Survey 2003–2017. 2019. https://nyc.gov/health/epiquery .
Coe SG, Crook JE, Diehl NN, Wallace MB. An endoscopic quality improvement program improves detection of colorectal adenomas. Am J Gastroenterol. 2013;108:219–226.
doi: 10.1038/ajg.2012.417
Ussui V, Coe S, Rizk C, Crook JE, Diehl NN, Wallace MB. Stability of increased adenoma detection at colonoscopy. Follow-up of an endoscopic quality improvement program-EQUIP-II. Am J Gastroenterol. 2015;110:489–496.
doi: 10.1038/ajg.2014.314
Wallace MB, Crook JE, Thomas CS, Staggs E, Parker L, Rex DK. Effect of an endoscopic quality improvement program on adenoma detection rates: a multicenter cluster-randomized controlled trial in a clinical practice setting (EQUIP-3). Gastrointest Endosc. 2017;85:538–545.e4.
doi: 10.1016/j.gie.2016.07.042
Kaminski MF, Anderson J, Valori R, et al. Leadership training to improve adenoma detection rate in screening colonoscopy: a randomised trial. Gut. 2016;65:616–624.
doi: 10.1136/gutjnl-2014-307503
Richards CA, Kerker BD, Thorpe L, et al. Increased screening colonoscopy rates and reduced racial disparities in the New York Citywide campaign: an urban model. Am J Gastroenterol. 2011;106:1880–1886. https://doi.org/10.1038/ajg.2011.191 .
doi: 10.1038/ajg.2011.191 pubmed: 22056567

Auteurs

Eugenia N Uche-Anya (EN)

Department of Medicine, Columbia University Irving Medical Center, 177 Fort Washington Avenue, New York, NY, 10032, USA. enu7001@nyp.org.

Jennifer J Brown (JJ)

New York City Department of Health and Mental Hygiene, New York, USA.

Charles Asumeng (C)

New York City Department of Health and Mental Hygiene, New York, USA.

Jared Striplin (J)

New York City Department of Health and Mental Hygiene, New York, USA.

Mari Carlesimo (M)

New York City Department of Health and Mental Hygiene, New York, USA.

Marian Krauskopf (M)

New York City Department of Health and Mental Hygiene, New York, USA.

David Greenwald (D)

Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, USA.

Brett Bernstein (B)

Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, USA.

Steven Itzkowitz (S)

Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, USA.

Felice Schnoll-Sussman (F)

Division of Gastroenterology and Hepatology, Department of Medicine, Weill Cornell Medical Center, New York, USA.

Benjamin Lebwohl (B)

Department of Medicine, Columbia University Irving Medical Center, 177 Fort Washington Avenue, New York, NY, 10032, USA.
Department of Epidemiology, Columbia University Mailman School of Public Health, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH